Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
O. Kotsiou (Larissa, Greece), D. Siachpazidou (Larissa, Greece), C. Pastaka (Larissa, Greece), C. Hatzoglou (Larissa, Greece), M. Kechagia (Athens, Greece), V. Stavrou (Larissa, Greece), E. Gogou (Larissa, Greece), C. Varsamas (Larissa, Greece), N. Economou (Athens, Greece), G. Seitanidis (Larissa, Greece), K. Gourgoulianis (Larissa, Greece). Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment. 2146

Member's Comments

No comment yet.

Related content which might interest you: Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004 Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP Source: Eur Respir J 2007; 30: 496-500 Year: 2007 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007 Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004 Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Plasma endothelin-1 (ET-1) levels in obstructive sleep apnea (OSA) patients and effect of continouous positive airway pressure (CPAP) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Serum vitamin D, physical activity and the obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Continuous positive airway pressure treatment associates with decreasing glycosylated hemoglobin (HbA1c) even in euglycemic obstructive sleep apnoea patients within normal HbA1c range Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients Source: International Congress 2017 – CPAP therapy Year: 2017 Dynamics of metabolic parameters after 3 days continuous positive airway pressure in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006 Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004 Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004 Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004 CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Source: Eur Respir J 2008; 32: 1009-1015 Year: 2008